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ABSTRACT
Thymic epithelial cells (TECs) are indispensable for T cell development and
maturation. Therefore, damages to the thymic epithelial cells are detrimental to thymic
function and immune response. In young healthy individuals, TECs have a high
regenerative potential and are capable of renewal from serious damage; however, the
molecular mechanism of this recovery is unclear. A recent study has shown that IL-22producing ILCs are present in the mouse thymus and can regenerate thymic epithelial
cells following radiation induced injuries (7). However, it is unknown whether IL-22producing cells are also found in the human thymus. Thus, the goal of this study is to
identify IL-22 producing cells in the human thymus and to determine the mechanism by
which IL-22 production is modulated. IL-22 is an effector cytokine that has been linked
to promoting epithelial survival and proliferation within several secondary lymphoid
tissues organs of mice and humans (53). To investigate the presence of IL-22-producing
cells in the human thymus, we used flow cytometry and Reverse Transcriptase-PCR (RTPCR) to analyze IL-22 expression in human pediatric thymocytes.
We reported that the highest percentage of IL-22-producing cells found in ex vivo
thymocytes are the LIN-RORγt+IL-22+ cells and CD4+ RORγt+IL-22+ T cell subsets.
We also reported that the production of IL-22 by the LIN-RORγt+IL-22+ cells and the
CD4+ RORγt+IL-22+ T cells are not solely modulated by TECs. Furthermore, although
the frequency of circulating RORγt-expressing ILC3-derived IL-22 increased following
x

PBMC co-cultured with TECs, we could not rule out whether this effect is likely due to
allogenic T cell response and/or cytokines produced by the activated allogenic T cells.
Since so much is still unknown about IL-22 biology, particularly in the human thymus,
the results from study contribute to our current understanding of the biology of IL-22
with the expectation that the new findings provide opportunities towards elucidating the
mechanism of thymus regeneration, repair and maintenance.

xi
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CHAPTER ONE
INTRODUCTION – LITERATURE REVIEW
Thymic function and thymic epithelial cells
The thymus is an essential lymphoid organ in which T cell development occurs in mice
and humans. Following T cell maturation, single positive CD4+ and CD8+ T cells are
exported from the thymus into the peripheral and made up the T cell pool with T cell
repertoire required for an effective immune response against non-self as well as
pathogens (1). Even though age dependent thymic involution affects T cell development
and the output of naïve T cells, more evidences are emerging to suggest that a normal
thymus can export mature T cells throughout life, although with reduced capacity (1, 2,
3).
One crucial component of the thymic microenvironment is the thymic epithelial
cells (TECs) which through cell-cell interactions, cytokine productions and chemokine
secretions induce the development and differentiation of functional T cells from
hematopoietic stem cells, a process term thymopoiesis (1-3). The thymic epithelium is
susceptible to deleterious factors such as stress, inflammation, chronic infections and
immunosuppressive drugs, which can lead to impaired thymopoiesis (2-5). Harmful
factors such as stress and inflammation can cause tissue injuries. The thymus is believed
to be able to recover from these tissue injuries (2-3). However, a more extensive tissue
damage such as that caused by myeloabative conditioning for organ transplantation can
cause stromal cell injury and thymocyte death leading to lymphopenia (2, 3-6). Previous
studies have shown that lethal or sublethal total body irradiation in mice lead to a
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dramatic shrinkage of thymic volume and a significant decrease in thymic cellularity (7,
8). For individuals like patients with chronic infections such as HIV, or patients with
complications after transplantation such as GVHD, the regeneration of TECs is crucial to
maintain thymus homeostasis and thymopoiesis. However, factors that contribute to the
proliferation of TECs following damage are not well defined. In fact, there are limited
studies investigating the role of TECs in prolonging/restoring thymic function (3). Since
the thymus is such an important organ in host defense, therapeutic strategies are needed
to regenerate the thymic epithelium to restore thymic function and to re-establish the T
cell repertoire following T-cell immunodeficiency. In this context, it is necessary to
investigate factors that contribute to the maintenance of homeostasis within the thymic
microenvironment and particularly their role in triggering the regeneration program of
TECs.
Interleukin 22
IL-22 is a newly characterized class 2 α-helical cytokine that is a member of the
interleukin-10 family of cytokines (8-12). The human IL-22 shares 79% homology with
the mouse IL-22; the IL22 gene is located on human chromosome 12 (9, 12, 14). IL-22
signals through a heterodimer receptor complex (IL-22R) which comprised of the
subunits IL-22R1 (IL22Rα1) and the IL-10R2 (IL-10Rβ2) (9-16). IL-22 binds first to IL22R1, and then the IL-22/IL-22R1 complex binds to the IL-10R2 to generate downstream
signals (9-16). IL-22 uses the Jak-STAT signal transduction pathway to
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induce the phosphorylation of kinase JAK1 and Tyk2 and the STAT1, 3, and 5
transcription factors which then induce proliferative and anti-apoptotic pathways (9, 12,
and 13). IL-22 has been shown to also induce MAP kinase, MER/ERK, JNK and p38
signaling pathway (9, 13, and 16). The IL-22R receptor expression is restricted to nonimmune cells with epithelial origin such as intestinal epithelial cells, respiratory epithelial
cells, keratinocytes, acinar cells and hepatocytes; IL-10R is ubiquitously expressed (916). Wolk et al. showed that there is basal level of IL-22Rα1 expression in the skin,
pancreas, intestine, liver, lungs and the kidneys (13.14).

Figure 1. IL-22 signaling pathway. IL-22 binding to IL-22 receptor complex leads to
the activation of the receptor-associated Janus kinases JAK1 and Tyk2, followed by
activation of transcription factors STAT3, and often STAT1 and/or STAT5. Other
signaling pathways that are recruited by this receptor are MAPK (Mitogen Activated
Protein Kinase), p90RSK and p38.
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Therefore, IL-22 signals non-immune cells, but it is produce by immune cells (13,
14). Binding of IL-22 to its membrane receptor IL22Rα1/IL10Rβ2 is regulated by the
competitive binding to the soluble IL-22 binding protein (IL-22Rα2) which has a higher
affinity for IL-22 than IL-22Rα1 (17, 18). The source of IL-22 binding protein is mainly
CD11+ c dendritic cells (DC). IL-22 binding protein is found in many cells and tissues
such as the lungs, intestine, skin, pancreas, thymus and spleen (17).
IL-22 function in different tissues
IL-22 receptors are expressed by various cells including keratinocytes,
hepatocytes, tracheal and colonic epithelial cells (9-15). There are many documented
findings that support a role for IL-22 as a mediator of epithelial barrier function and in
maintaining epithelial homeostasis (9-15). IL-22 promotes proliferation and survival by
inducing expression of proteins (Muc1, Muc3, Muc10, Muc13) that make up the
protective mucus layer, pro-survival genes (Bcl-2, Bcl-XL and Mcl-1), and proliferative
factors (c-Myc, cyclinD1, Rb2 and CDK4) (9, 21, 23). In additional, several studies have
shown that IL-22 induces mRNA expression of acute phase proteins such as serum
amyloid A, α1- antichymotrypsin, and haptoglobin in the HepG2 human hepatoma cell
line (13). IL-22 has differential functions in many tissues many of which includes
preventing tissue destruction, enhancing wound healing, promoting epithelial cell
regeneration, and inhibiting differentiation of keratinocytes (6-30). Below, I will provide
a comprehensive review of the role of IL-22 at different barrier tissues.
Very recently, studies have begun to unravel IL-22 role in tissue regeneration in
the thymus (7, 8). Van der Brink and colleagues showed that following depletion of
CD8+CD4+ T cells by radiation treatment, or by administration of synthetic steroid the
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levels of IL-22 in the mouse thymus were elevated. They also demonstrated that IL-22deficient mice displayed impaired thymic recovery; however, upon treatment with
exogenous IL-22, thymic recovery was enhanced. In this study, IL-22 was produced by
LTi cells that were induced by IL-23-secreting DC. The authors suggested that IL-22
augments the proliferation and survival of thymic epithelial cells following thymic insult
(7). Concurrently, Pan et al. also showed that increased IL-22 expression confers
protection following thymic damage induced by high dose of dexamethasone and total
body irradiation; both contribute to the depletion of CD8+ CD4+ T cells in the mouse
thymus. In addition, these investigators demonstrated that Foxn1 a transcriptional factor
that promotes the development of TEC, as well as, genes such as CCL25, and DLL4 were
upregulated in TECs following thymic injury. They concluded that thymic insults
promote the regenerative program in TECs (8).
It is well documented that IL-22 has protective roles against enteropathogenic
bacterial infections such as Citrobacter rodentium and Salmonella enteritidis (15, 16, 19,
20). The protection occurs when IL-22 acts directly on intestinal epithelial cells, leading
to the increase production of antimicrobial proteins such as RegIIIβ and RegIIIγ that
promote immune responses against these gut pathogens (15, 16, 19).
Further investigation into the role of IL-22 in the gut and the gut inflammation has
led to evidences suggesting that IL-22 has both an inflammatory and a protective role in
inflammatory bowel disease (IBD). In one type of IBD (Crohn’s disease), studies have
shown that upregulated IL-22 levels act on subepithelial myofibolast and promote the
expression of other pro-inflammatory cytokines and matrix degrading proteins. Patients
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with Crohn’s disease have been shown to have an elevated number of CD4+ IL-22producing cells as well as an increased level of LPS-binding protein (23).
On the other hand, studies have shown that IL-22 confers protection when colitis,
another IBD, was induced by acute dextran sodium sulfate (19). In this colitis model, IL22 acts on the intestinal epithelial cells, resulting in increased expression of proinflammatory genes necessary for enhancing the integrity of intestinal barrier through
inducing intestinal cell migration and antimicrobial peptides (19).
Yet in another study, in which intestinal inflammation is induced by GVHD, IL22 was shown to have a protective role. Hanash et al., corroborated this finding in their
study by using bone-marrow chimeras as secondary transplant recipients to elegantly
illustrate that transplantation of MHC mismatched bone marrow into IL-22-deficient
recipients caused more severe pathology in the intestinal tract (21). The findings
demonstrated that the recipient-derived hematopoietic cells produce IL-22 which protects
epithelial stem cells from GVHD-induced cell death (21).
In addition to the GI tract, IL-22 also has been shown to play a protective role in
inflammatory conditions in organs such as the liver, pancreas and lungs. A report by
Zenewicz et al. studying the role of IL-22 on hepatocytes during acute liver inflammation
demonstrated that IL-22 deficient mice are extremely susceptible to hepatitis, and that
adoptive transfer of IL-22+ Th17 cells protected hepatocytes during ConA- mediated
hepatitis (22). In another study, it was also shown that IL-22 prevents systemic
inflammation though a mechanism that involves expression of lipopolysaccharidebinding protein in hepatocytes (23). Furthermore, IL-22 confers survival of hepatocytes
by upregulating anti-apoptotic proteins such as Bcl-xL and Bcl-2 via STAT3 (23).
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Data from previous work also suggest that IL-22 mediates direct protection
against tissue destruction in a mouse model of hepatitis and acute pancreatitis (24-26).
Radaeva et al. reported that there is a significant IL-22 production and T-cell infiltration
following Concanavalin A induce hepatitis (24). Colletti et al. expanded on these findings
showing that IL-22 plays a direct role in hepatocytes protection which is not limited to T
cell-mediated hepatitis. They further demonstrated that there was an increase in IL-22Rα
levels at early time point after partial hepatectomy, and that blocking of IL-22 with a
neutralizing IL-22 antibody could delayed liver regeneration (25). In the context of the
pancreas, Xue, Jing et al., found that IL-22 provides protection against acute pancreatitis
by upregulating IL-22Rα1 levels on pancreatic acinar cells following the administration
of exogenous IL-22. The effect of administration of IL-22 led to a reduction of acute
pancreatitis and associated lung injury, which is mediated through AhR. Mice with
blunted AhR activation develop acute pancreatitis and the protective effect of IL-22 is
specific because IL-22 blockade abrogate the effect (26).
In the lungs, studies have shown that IL-22 is critical for promoting host
protective immunity against bacterial pathogens, reducing inflammation and promoting
lung tissue repair (27-30). For example, during Klebsiella pneumonia infection IL-22
promotes the production of inflammatory mediators such as IL-6 and G-CSF and
chemokines such as CXCL1, CXCL5, and CXCL9 from air way epithelial cells (27).
Although IL-22 have no substantial direct role on viral pathogens, Kumar et al. showed
that following epithelial cell damage by influenza infection in mice, IL-22 derived from
conventional NK cells were crucial for the regeneration of tracheal and epithelial cells
after injury (28). In this study, IL-22-deficient mice challenged with influenza virus failed
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to regenerate tracheal epithelial cells and displayed a decrease in the proliferation of
tracheal epithelial cells. However, adoptive transfer of IL-22 sufficient NK cells into IL22-deficient mice challenged with influenza virus restored the regeneration of tracheal
epithelial cells as well as protect against inflammation (28). In additional, Taube et al.
also showed a role for IL-22 produced by innate lymphoid cells in limiting allergenic
airway disease, since the administration of exogenous IL-22 to allergen sensitive Il-22
deficient mice prior to challenge with antigen displayed reduction of allergic asthma
mediated cytokines, as well as, a reduction in inflammation and airway constriction (29).
In addition to anti-inflammatory role, IL-22 has been suggested to play a proinflammatory role in psoriasis, a chronic autoimmune disease of the skin (14, 16, 31).
Investigators focus on characterizing the effect of IL-22 on keratinocytes have so afar
shown that IL-22 induces antimicrobial proteins, reduces differentiation-associated
protein, and promotes mobility regulating proteins such as matrix metalloproteinase 1 and
3 (13, 14).
The effect of IL-22 on keratinocyte mirrors the phenotype of psoriasis’s patients;
furthermore, psoriatic plaques and the blood of psoriasis’s patients displayed high
expression of IL-22 (14, 31). Wolk et al., confirmed the role of IL-22 in psoriasis with the
observation that transgenic mice that over-express IL-22 displayed psoriasis-like skin
alterations (31). Adding to this finding, Zheng et al., used IL-22-deficient mice to
demonstrate that the ablation of IL-22 diminished IL-23-dependent dermal inflammation
(32). Overall, these data demonstrate that depending on the
cytokine and tissue microenvironments or target cell types, IL-22 display either
protective or inflammatory effects (23-32).
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Innate lymphoid cells
IL-22 are produce by group three innate lymphoid cells (ILCs). ILCs are a
heterogeneous population of cells that are important in innate immunity and lymphoid
tissue formation (17, 19, 22-28). ILCs lack lineage markers (LIN-) and in humans are
defined as negative for CD1a, CD3, CD11c, CD34, CD123, TCRαβ, TCRγδ, BDCA2,
FcεRl, CD19, CD14 and CD16 (22-25). All LIN- ILCs express the lymphoid progenitor
marker IL-7 receptor α chain (IL-7Rα; CD127) and the cytokine common gamma (γc)
receptor chain (22, 27). ILCs require IL-7 and ID2 (inhibitor of DNA binding-2) for their
development and maintenance (23-27).
ILCs produce many helper (Th) cell-associated cytokines (Figure 2 and 3) and can
be divided into three distinct cell subsets: ILC1s, ILC2s and ILC3s based on their
cytokines production and transcription factors expression (17, 2-23-24, 28). Within the
group three ILCs (ILC3s) are subtypes that produce IL-22 and depend on the
transcriptional factor RORγt (RORC- human analogue) for their development and
function (16, 21-24, 28). In humans, RORγt+IL-22+ ILC3 cells express the natural
cytoxicity triggering receptor 46 (NKP46) as well as NKP30 and NKP44; NKP44 is
unique for humans and is not expressed in mice. The ILC3s subtype NCR+IL-22+ is the
proposed new nomenclature; previously, these cells have been referred to as NCR22,
NKR-LTi, NK22 and ILC22 cells (17, 23-28, 53). NCR+IL-22+ILC3s have been shown
to originate from a lineage distinct from the conventional Natural Killer (NK) cells
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Figure 2. Group 3 innate lymphoid cells (ILC3s). Group 3 ILCs are characterized
as LIN-cells (CD3-CD4-CD8-) that express the transcriptional factor RORγt. There
are three subgroups of ILC3s based on the expression of NCR and cytokine
production; NCR+ILC3 have been shown to produce only IL-22 while NCR-ILC3
and LTi cell produce IL-17 and IL-22. LTi cells are mostly present during fetal
development.

although they both express NK receptor (NKP44) and over 50% of NCR+ILC3s also
express CD56 (29, 30). As shown in Figure 2, other subtypes of group 3 ILC3s include
NCR-ILC3s and LTi cells. These cells also depend on RORγt and IL-7Rα but have been
shown to produce both IL-22 and IL-17. In mice and humans, NCR+IL-22+ILC3s are
present in secondary lymphoid organs such as the spleen, lungs, lymph nodes, tonsils and
other intestinal lymphoid tissue (17, 23-30). Murine studies have shown that ILC3s
development and function depended on several different cytokines, chemokines and
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transcriptional factors. ILC3s express the receptors IL-1R1, IL-7R, IL-23R, IL-2Rβγ and
c-kit (5, 17, 23, 22-24, 29). Studies have indicated that IL-22–producing ILC3s can be
activated by cytokines released by the epithelium (17, 28-31). These cytokines include
IL-23, IL-7, IL-21, IL-6 and IL-1β that can stimulate IL-22-producing cells
differentiation, function and survival (17, 22-31). In additional, ILC3s express CCR6 the
chemokine receptor for CCL20, which influences the localization and expression of IL22 and may be involved in the migration of ILC3s to different periphery tissues from the
bone marrow (17, 22, and 32).
The development of NCR+IL-22+ILC3 and the regulation
of IL-22 expression by environmental cues
The transcriptional factors RORγt, AhR and Notch have been shown in murine
models to be required for ILC3 development (9, 8, 17, 20, 24, 28, 29, 31). The lack of
RORγt in mice impairs the development of ILC3s (17, 28). Several studies have indicated
that mouse innate lymphoid cells that are RORγt negative fail to produce IL-22 (7, 8, 18,
24 and 26). Ahr-deficient mice showed reduced expression of IL-22 in the small intestine
and colon which suggest a role for AhR in the maintenance and functions of ILC3s (17,
39).
There are not many studies addressing the role of Notch signaling in the
development of ILC3s. These studies have shown that in mice, AhR induces ILC
development in a Notch -1 and Notch -2 dependent manners (33-35). Further evidence
supporting a role for Notch signaling includes studies which showed that blocking Notch
signaling in hematopoietic cells reduced the levels of NKp46+ ILCs in the intestinal
lamina propria (17, 28, 33, 36). Several studies have also link the role Notch signaling in
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ILC development and function within a specific microenvironment of ILCs (9, 17, 33-34,
36-38). One study has indicated that prolong Notch signaling in the mouse thymus
induced the differentiation of T cells over ILCs (9). Interestingly, another study has also
recently shown that higher strength Notch signaling favors ILC2s generation over T cells
in the human thymus (38).
IL-22 expression and regulation in T cells population
In humans, IL-22 is produced mainly by activated T cells and NK cells (9, 12,
13). The major αβ T cell subsets that produce IL-22 are T helper 22 (Th22) cells, Th1
cells and Th17 cells. The presence of the different cytokines (Figure 3) and the
expression of different transcriptional factors contribute to the differentiation and
maintenance of these cell types.
Th17 cells were the first cell subset to be characterize as IL-22 producers. It was
later shown that Th22 a subtype of Th17 cells produced IL-22 but not IL-17. It is unclear
whether RORγt is necessary for these cells function and maintenance, however like the
NCR+IL-22+ILC3s, Th22 cells express CCR6 (12,13). In human peripheral blood, about
35% of all IL-22-producing CD4+ T cells were Th1 cells (10). The cytokines IFN-γ and
Tbet are important for IL-22 production by the Th1 cells. Th1 cells have high expression
of IL-18R, and studies have shown that IL-12 and IL-18 synergize to enhance IL-22
expression in Th1 cells (10). Other αβ T cell subsets that produce IL-22 include a
functional distinct subset of CD8+T cell termed Tc22 cells. Studies have shown that IL21 can induce human naïve CD8+ T cells to differentiate into Tc22 cells, however, these
cells are found mostly in the tissue or blood following infection and cancer (12). These
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cells also express the transcriptional factor RORγt. Notch plays an important role in the
regulation of peripheral T cell differentiation. Since the Notch

Figure 3. The different subsets of IL-22-producing cells. The different cytokines
required for the differentiation of cells into the different subsets of IL-22-producing
cells.

ligand DL4 promotes the expression of RORγt+ and expansion of CD8+ T cells and
CD4+ T cells (40-42). Other innate cell types that produce IL-22 include γδT cells, NK
(natural killer) T cells and NK cells. Murine IL-22-producing γδT cells express high level
of IL-18R. (8). Studies have shown that in these cells IL-18 together with IL-23 induce
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IL-22/IL-17 production, and enhance RORγt+ and IL-23 expression (13). IL-22producing γδT cells express RORγt+, AHR and CCR6. Studies have also shown that
NKT cells isolated from mouse spleen can be stimulated by αCD3/αCD28 to produce IL22 (13, 28). IL-22-producing NK cells found in the gut mucosa have also been described
in both humans and mice.

CHAPTER TWO
SPECIFIC AIMS
Thymic epithelial cells (TEC) are an essential component of the thymic
microenvironment and play pivotal roles in the generation of mature T cells expressing T
cell receptor αβ chain through a process termed thymopoiesis (1-3). Thymic tissue
injuries caused by radiation, chronic inflammation, immunosuppressive therapies and
infection lead to alterations in thymic epithelial cell function and survival, resulting in
thymic dysfunction leading to compromised immune (1-4). Therefore, the regeneration of
thymic epithelial cells following these situations is critical to maintain thymic function.
Several murine studies have shown that the production of IL-22 by IL-22- producing
cells promote epithelial cells proliferation, differentiation and survival in the gut, lungs,
liver and spleen (7-12). Recent studies in mice have shown that following radiation
treatment, innate lymphoid cells group 3 (ILC3s) in the thymus produce IL-22 that
induces epithelial cell proliferation, leading to the regeneration of thymic function caused
by the radiation induced thymic injury (7). Whether IL-22-producing ILC3s are also
present in the human thymus has yet to be investigated. I hypothesized that IL-22producing cells are present in the human thymus. Because, TECs are known to function
through cell-cell contacts and the production of cytokines, I further hypothesized that that
interaction between TEC and IL-22-producing cells modulates IL-22 expression. Lastly,
because TEC express the Notch ligands Delta-like 1 (DL1) and Delta-like 4 (DL4), I
investigated whether Notch signaling mediates IL-22 expression in
15
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IL-22-producing cells. To test the above hypotheses, I proposed the following two
specific aims:
Specific Aim 1. To determine if IL-22-producing cells are present amongst human
thymocytes and the identities of the IL-22-producing cells.
a) Determine whether the LIN- (CD3-CD4-CD8-CD56-) RORγt+ expressing IL-22
cells (ILC3s) are present in pediatric human thymocytes by flow cytometry.
b) Determine whether the sorted LIN- (CD3-CD4-CD8-CD56-) RORγt+ (ILC3s) from
pediatric human thymocytes express IL-22 mRNA.
Specific Aim 2: To determine if thymic epithelial cells (TECs) modulate IL-22
expression by thymic and circulating ILC3s and whether the modulation is
mediated by Notch signaling via DLL4 ligand.
a) Determine whether co-culturing human thymocytes and TECs increases the
frequencies of LIN-RORγt+IL-22-producing cells in a Notch dependent manner.
b) Determine whether TECs also regulate the frequency of circulating peripheral blood
LIN-RORγt+IL-22-producing cells in in a Notch dependent manner.

CHAPTER THREE
RATIONALE AND EXPERIMENTAL DESIGN
Specific Aim 1. To determine if IL-22-producing cells are present amongst human
thymocytes and the identities of the IL22-producing cells.
.
Rationale: A recent study has identified a population of RORγt+ innate lymphoid cells in
the mouse thymus. These cells were shown to be critical for thymic tissue repair
following radiation damage (21, 22). Literatures have established that RORγt+ IL-22producing cells are present in tonsil, lung, spleen and intestine in both mice and humans
(17, 23-30). Although RORγt+ IL-22-producing cells are found in the mouse thymus, it is
unknown whether phenotypically similar populations of RORγt+IL-22-producing cells
are also present in the human thymus. The goal of Aim 1 is to determine whether
RORγt+ IL-22-producing cells (ILC3s) are present in the human thymus.
Experimental Design:
1A. Determine if the LIN- RORγt+ IL-22-producing cells are present in pediatric
human thymocytes. To investigate the presence of IL-22-producing (ILC3s) in the
human thymus, we used flow cytometry to determine the phenotype of IL-22-expressing
cells within cryopreserved ex vivo pediatric human thymocyte samples. For analysis of
the percentage of RORγt+ IL-22-producing cells within the lineage negative cells, two
different negative control method were used: an isotype control for both RORγt and IL22, and a RORγt negative control since cells that are RORγt- fail to produce
17
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IL-22. All flow cytometry data were analyzed using fluorescent activated cell sorting
(FACS) on a Fortessa and FlowJo software version 7.6.5 (Tree Star, Inc, Ashland, OR).
The average percentages of LIN- IL-22+RORγt cells in thymocytes from three different
donors were calculated for statistical analysis.

1B. Determine whether sorted lineage negative pediatric human thymocyte sample
express IL-22 mRNA. To confirm the presence of IL-22, lineage negative (CD3-CD4CD8-) thymocytes and the T cells subsets (CD4+ T cells, CD8+Tcells, CD8+CD4+ T
cells and CD3-CD4+CD8+ T cells) within the human thymocyte population were sorted
from ex vivo cryopreserve human thymocytes and IL-22 transcript levels of the sorted
populations were measured by RT-PCR. Expression of GAPDH was used to establish
relative expression levels.
Specific Aim 2: Determine if thymic epithelial cells (TECs) modulate the expression
of IL-22 in RORγt+ IL-22+ cells and whether modulation of IL-22 expression is
Notch dependent.
Rationale: TECs have been shown to an essential function in the development of
T cells (1, 2, 4, and 14). TECs mediate their functions through bidirectional signaling
involving direct contact by ligand–receptor interaction and cytokine production (4, 14, 20
and 21). IL-22-producing cells (ILC3s) can be activated by cytokines produce by
epithelium (17, 28). TECs has been shown to express Delta-like 1 and Delta-like 4
ligands that bind to the receptor Notch-1 expressed on other cell types (22, 23, 24).
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Several studies have implicated a role for Notch signaling in innate lymphoid cell
development and function through the induction of Notch 1 and Notch 2 by AhR (9, 17,
29, 34, 35, 37-39 and 30). Our first goal is to determine whether interaction between
thymocytes and TECs can increase the percent and total cell number of IL-22-expressing
cells within the thymocyte population; and secondly, to investigate whether IL-22
expression can be increase by TECs in a Notch dependent manner.
Experimental Design:
2A. Determine if interaction between thymocytes and TECs can increase the
frequencies of LIN-RORγt+ cells in the human thymocyte population and whether
this modulation is Notch dependent. To test whether Notch plays a role in TEC
regulation of IL-22 expression by LIN- RORγt+ cells, we used flow cytometry to
compare the percent and the total cell numbers of LIN- RORγt+ IL-22-producing cells
when thymocytes were co-cultured with two different TEC cell lines: TEC-DL4 which
overexpress the Notch ligand DL4 and TEC-84 which expresses low levels of human
DL4. Thymocytes were cultured for 2 and 4 days with TEC lines and harvested following
2 hrs of monensin treatment. The cultured thymocytes were analyzed for cytoplasmic IL22 by flow cytometry. Isotype controls for RORγt and IL-22 were used to define RORγt
positive and IL-22 positive population in the LIN- thymocyte subset. The Mann-Whitney
U test was used for statistical test and significance was determined at p≤0.05.
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2B. Determine whether TECs also regulate the frequency of circulating peripheral
blood LIN-RORγt+IL-22-producing cells in in a Notch dependent manner.
Rationale: The microenvironment of ILCs has been shown to have different influence on
their development and their regulation (8, 25, 26, 21, 28 and 31). Since ILC3s have been
shown present within the peripheral blood, we next determine whether interaction
between PBMCs and TECs could increase d IL-22 expression in ILC3s and whether
enhanced IL-22 expression is Notch dependent. To determine if interaction between
PBMCs and TECs can increase the percentage and the total cell numbers of RORγtexpressing ILC3s within peripheral blood. Human PBMCs were co-cultured with TECDL4 or TEC-84 and then the non-adherent cells were analyzed using flow cytometry. To
test this, PBMCs were cultured 4 days with each TEC line, harvested following monensin
treatment and IL22-producing cells were assessed by flow cytometry. For analysis, I
gated on the LIN- population, then assess fractions that are positive for RORγt and IL-22
as described in previous sections. The Mann-Whitney U test was used for statistical test
and the significance was determined at p≤ 0.05.

CHAPTER FOUR
RESULTS
Identifying LIN-IL-22+RORγt +cells within the human thymus
IL-22 expressing cells have been identified in mice thymus, however it has yet to
be shown that a phenotypically and functionally similar cell subset is present in the
human thymus. We have investigated the presence of IL-22-producing cells in the human
thymocytes. As shown in Figure 4, LIN- cells were selected for which were further
analyzed for the IL-22+RORγt+ cells. The quadrants for positive and negative were
based on unstained cells, cells stained with isotype control for IL-22 and RORγt, and by
RORγt negative controls gating. Based on our isotype control gating strategy, we
observed that an average of 1.08 % of the lineage negative thymocyte population were
RORγt+ IL-22+ cell (Table 1). In contrast, gating based on RORγt negative population
showed an average 1.49% RORγt+ IL-22+ cells (Table 2). Since these cells express the
identification markers associated with group 3 innate lymphoid cells we term them ILC3s
and therefore there is an average 1.0-1.5% ILC3s found in the human thymus at steady
state.
We next evaluated the presence of other IL-22-producing cells such as γδ T cells,
CD8+ and CD4+ T cells which are found in the human thymus that have been indicated
to produce IL-22 in other organs (17, 23-30). Figure 5 is a representative flow cytometry
profile of the CD3+CD8+CD56- T cells. The CD4- CD8- T cells, CD4+ T cells, CD8+T
cells and CD4+CD8+ T cells were defined within the CD4 CD8 lymphocyte gate
followed by gating on CD3+ and CD56- cells.
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Figure 4. LIN- IL-22+ RORγt+ cells are detected within the human thymus. (A)
Identification of LIN- cells. 1-2 x 106 ex vivo thymocytes (sample 64) were stained
with surface markers CD3, CD4, CD8, and CD56 and then intracellularly stained for
IL-22 and RORγt; middle panel shows the gating for CD4-CD8- cells; right panel
shows gating for the CD3 negative and CD56 negative population. (B and C) Two
strategies to detect RORγt pos IL-22 pos populations: (B) Based on isotype control for
RORγt; (C) Based on RORγt neg and pos populations. Data shown are from a
representative analysis of thymocyte sample 64
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Figure 5. CD3+ IL-22+ RORγt+ cells are detected within the human thymus.
A) Identification of CD3+CD8+CD56- cells. 1-2 x 106 ex vivo thymocytes (sample 64)
were stained with surface markers CD3, CD4, CD8, and CD56 and then intracellularly
stained for IL-22 and RORγt. Thymocytes were gated first on CD4-CD8+ then on the
CD3+ CD56- population. Data shown are a representative profile of CD3+CD8+CD56cells using thymocyte sample #64. B and C) The CD3+CD8+CD56-RORγt+IL-22+ cells.
Data are representative of the gating strategy for isotype control and RORγt negative
gating to determine IL-22-expressing cells.
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Table 1. Distribution of RORγt+ IL-22+ cells in human thymus Three ex vivo cryopreserved
pediatric thymocyte samples were evaluated to determine the phenotype of IL-22-expressing
cells within the human thymus. 1.0-2.0 x 106 thymocytes were stained with surface markers
CD3, CD4, CD8, and CD56 then intracellularly stained for IL-22 and RORγt. The percent of
CD4, CD8 populations was determined from the viable lymphocyte fraction followed by
selecting for CD3 fractions. Quadrants for positive and negative were based on isotype control
for IL-22 and RORγt.

For the analysis of the percentage of RORγt+ IL-22-producing cells within the
thymocytes population again we used our two-different negative control method: an
isotype control for both RORγt and IL-22, and gating on the RORγt negative population.
We found cells within the thymocyte population that were CD3+CD8+ (CD8 + T cells),
CD3+CD4+CD8+ (double positive (DP) cells), CD3+CD4-CD8- (double negative (DN)
cells) and CD3+CD4+CD8-(CD4+ T cells) that express both RORγt and IL-22. Using the
isotype control (Table 1), we found that an average percentage of the 1.11% CD3+CD4+
T cells, 1.81% CD3+CD8+T cells and the 0.63% CD3+CD4-CD8- cells express both
RORγt and IL-22.
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Using the RORγt negative population gating (Table 2) we found that an average of
1.13% CD3+CD4+ T cells, 2.89% CD3+CD8+ T cells and the 3.77% CD3+CD4-CD8- T
cells that express both RORγt and IL-22. Taken together the data indicate that 1.2% of
IL-22-producing cells in the human thymus are CD4+ T cells, 2.4% are CD8+ T cells,
and 2.2% are double negative, or double positive cells. There is a lot of variability
between the percentages of each cell population from the different samples. These may
be due to biological variability in the human samples.

Table 2. The frequency of RORγt+ IL-22+ thymocytes in pediatric human
thymus determined by using RORyt negative population gating strategy.
Three ex vivo cryopreserved pediatric thymocyte samples were evaluated to determine
the phenotype of IL-22-expressing cells within the human thymus. 1.0-2.0 x 106
thymocytes were stained with surface markers CD3, CD4, CD8, and CD56 then
intracellularly stained for IL-22 and RORγt. The percent of CD4CD8 populations was
determined from the viable lymphocyte fraction followed by selecting for CD3
fractions. The percentage of RORγt+ and IL-22+ positive cells were based gating on
RORγt negative population.
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IL-22 mRNA expression in sorted LIN- cells and T cell subsets
To confirm that IL-22 was expressed in subsets of human thymocytes, we next
investigate IL-22 mRNA expression in these thymocyte subsets. Cells were sorted based
on the expression of CD3, CD4, CD8 and CD56. Five different cell subsets were sorted;
these include: CD3+CD4+CD56-(CD4+ T cells), CD3+CD8+CD56- (CD 8+ T cells),
CD3+CD4-CD8-CD56- (DN cells), CD3+CD4+CD8+ (DP cells) and CD3-CD4-CD8cells (ILC3s). The RNA was isolated and IL-22 mRNA expression was evaluated in the
five different cell subsets (Table 3).

Table 3. The mRNA expression of IL-22 in sorted cell subsets. 40x106 cells were
sorted based on the expression of CD3, CD4, CD8 and CD56. The RNA was isolated
for each of the sorted subsets and used to perform RT-PCR for IL-22 expression. The +
sign indicates positive IL-22 expression, *NP indicates that the IL-22 was not evaluated
while – sign indicates no IL-22 expression. Data are representative of three different
patient thymocyte samples.
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Figure 6. IL-22 mRNA expression in sorted LIN- and T cell subsets. IL22 relative to GAPDH in LIN- cells sorted from ex vivo cryopreserved
thymocyte samples as determined by RT- PCR. PBMC was used as a positive
control since it has been shown that PBMC have IL-22 expression. Data are
representative of 3 independent experiments using thymocyte 64.

We observed differential expression of IL-22 in the cell subsets for the 3 different
thymocyte samples assessed. Thymocyte sample 64 (Figure 6) displayed high IL-22
mRNA expression by all cell subsets except CD4 + T cells that were not process due to
low quality RNA. For thymocyte sample 12 we observed IL-22 mRNA expression for
only ILC3s and CD4+ cells. While thymocyte 21 showed detectable level of IL-22
mRNA by only CD4+ cells. Overall we found that there was expression of IL-22 mRNA
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in the CD3-CD4-CD8- cells and CD3+CD4+CD56- cells with variable expression of IL22 mRNA in the CD3+CD8+CD56- cells, and CD3+CD4+CD8+ cells (Table 3).
The expression of IL-22 by IL-22+RORγt+ cells following TEC/thymocyte
co-culture
We analyzed thymocytes cultured with TEC for the expression of IL-22. Figure 6
is a representative flow panel showing IL-22 and RORγt expression following thymocyte
co-culture with TEC; the negative and positive quadrants were established by using both
isotype control and RORγt negative control. The data suggest that TECs have some effect
on the expression of IL-22 by LIN-RORγt+ cells. However, these differences are not
statistically significant (Figure 7). We also found that the percentage and total cell
number of the LIN- RORγt+ IL-22+ cells, and the total cell number of LIN- RORγt+
cells within the thymocyte population co-cultured with TEC did not statistically increased
in comparison to cells cultured without TEC (Figure 8).
Similarly, we compared the percent and the total cell numbers of the CD3+ RORγt+ IL22+ T cell subsets within the thymocyte population of each treatment conditions, and
found no significant changes in the percent and the total cell number of CD3+ RORγt+
IL-22+ cells, or in the total cell number of CD3+ RORγt+ cells subsets following
thymocyte-TEC co-culture (data not shown).
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Figure 7. IL-22 and RORγt expression of thymocytes co-cultured with thymic
epithelial cells (TECs). Following TEC84 or TECDL4 co-culture with thymocytes
(sample 64), thymocytes were harvested, treated with monensin for 2 hrs and analyzed
for the expression of CD3, CD4, CD8, IL-22 and RORγt. The positive and negative
quadrants were determined using isotype control. The data shown are representative
of four independent experiments.IL-22 and RORγt expression in the lineage negative
cells within thymocyte population.
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Figure 8. The frequency of IL-22+RORγt+ cells among thymocytes does not
significantly increase following TEC/thymocytes co-culture. (A and B) Boxplot of
RORγt+ IL-22+ cells percent determined by isotype control and RORγt+ negative
gating respectively. (C and D) LIN-RORγt+ cells and LIN-RORγt+ IL-22+ cells. Data
are presented as the total cell number of LIN-RORγt+ cells and LIN-RORγt+ IL-22+
cells within the thymocyte population of co-culture cells. Data represent one of four
independent experiments. Boxplot depicts mean, ± SEM and statistics (n.s: not
significant, p>0.05) represent Mann-Whitney comparisons.
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The expression of IL-22 by IL-22+RORγt+ cells following TEC/PBMC co-culture
Upon the examination of IL-22 expression following TEC/PBMC co-culture we
found that the frequencies of the LIN-RORγt+ IL-22+ cells within the PBMC/TEC coculture increased in comparison to the frequencies of LIN-RORγt+ IL-22+ cells cultured
alone (Figure 9 and 10). Statistical analysis using data from both controls confirmed that
the LIN-RORγt+ IL-22+ cells within the PBMC-TECDL4 co-culture significantly
increased in comparison to LIN-RORγt+ IL-22 cells cultured alone (Figure 11A and
11B). Cell co-culture with TEC84 showed significant increased when evaluated with
negative gating but not isotype control gating. Thus, we observed no significant
difference in the expression of IL-22 by ILC3s when co-cultured with TEC expressing a
low level of Notch ligand or a high level of Notch ligand based on negative control gating
strategy. However, we did observe a significant difference between ILC3s culture with
TEC with low Notch ligand expression or high Notch ligand expression based on our
isotype control. While the percentages changed significantly, the total number of LINRORγt+ IL-22+ cells and LIN-RORγt+ cells within PBMC-TEC co-culture showed no
significant difference as compared to the PBMC cultured alone (Figure 11C and 11D).
We also found that the frequency of IL-22+RORγt+ cells within the CD3+CD4+
(Figure 12) and CD3+CD8+ (Figure 13 and 14) population significantly increased
following PBMC/TEC co-culture using both gating strategy. However, there is no
statistically significant difference between cells that were culture with TEC that have low
Notch ligand expression or high Notch ligand expression.
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Figure 9. IL-22 and RORγt expression following PBMC/TEC co-culture. Following
72hr co-culture with TEC84 or TECDL4 PBMCs were treated with monensin for 2 hrs and
analyzed for the expression of CD3, CD4, CD8, IL-22 and RORγt. The positive and
negative quadrants were determined using isotype control. The data shown are a
representative of four independent experiments.

There were no differences in the total number of IL-22+RORγt+ cells or RORγt+ cells
within the CD3+CD4+ (data no shown) and the CD3+CD8+ (Figure 14C and 14D)
populations in the PBMC cultured alone, or co-cultured with low Notch ligand
expressing or high Notch ligand expressing TECs.
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Figure 10. The percentage of LIN- RORγt+ cells following PBMC/TEC coculture. LIN- RORγt+ IL22+ cells were analyzed using RORγt negative gating to
determine positive and negative staining for IL-22. Numbers shown are percentages
within each fraction. Data are a representative of 4 different PBMC-TEC co-cultures.
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Figure 11. The frequency of LIN- RORγt +IL-22+ cells increased when PBMC were
cultured with TEC. (A) Boxplot showing the percentages of RORγt+ IL-22+ cells as
determined by isotype control. (B) Boxplot showing the percentage of RORγt+ IL-22+ cells
determined by RORγt negative gating. (C and D) The total number of LIN- RORγt+ and LINRORγt +IL-22+ cells did not increase when cultured with TEC. Data were obtained using
isotype control. Similar data were obtained using RORγt negative control. Boxplots depict
mean, ± SEM and the statistics (*p<0.05) are represented by Mann-Whitney comparisons.
Data are representative of 4 independent experiments.
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Figure 12. The frequency of CD3+CD4+IL-22+RORγt+ cells significantly increases when
PBMC were cultured with TEC-DL4. Following 72hr co-culture with TEC84 or TECDL4
PBMCs were treated with monensin for 2 hrs and analyzed for the expression of CD3, CD4,
CD8, IL-22 and RORγt. The positive and negative quadrants were determined using isotype
control. The data shown are representative of IL-22 and RORγt expression in the CD3CD8
cells within lymphocyte population of cultured cells. Data are representative of 4 independent
experiments.
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Figure 13. The frequency of CD3+CD8+ IL-22+RORγt+ cells increases when
PBMC were cultured with TEC-DL4. Following 72hr co-culture with TEC84 or
TECDL4 PBMCs were treated with monensin for 2 hrs and analyzed for the expression
of CD3, CD4, CD8, IL-22 and RORγt. The positive and negative quadrants were
determined using isotype control. The data shown are representative of IL-22 and
RORγt expression in the CD3CD8 cells within lymphocyte population of cultured
cells.

37

Percentage of CD8+IL-22+ cells
determined by Isotype control

A

Percentage of CD8+IL-22+ cells
determined by RORγt negative
gating

B

Total number of CD8+RORγt +IL-22+
cells using Isotype control

Total number of CD8+RORγt +cells
using Isotype control

C

D

Figure 14. The frequency, but not the total cells number of CD3+CD8+ cells increases
when PBMC were cultured with TEC-DL4. (A). Boxplot showing the percentage of CD8+
RORγt+ IL-22+ cells as determined by isotype control. (B) Boxplot showing the percentage of
CD8+RORγt+ IL-22+ cells determined by RORγt negative gating. (C and D) Boxplot of the
total cell number of CD8+RORγt+ and CD8+RORγt+ IL-22+ cells did not increase when
cultured with TEC. Data were obtained using isotype control. Similar data were obtained using
RORγt negative control. Boxplots depict mean, ± SEM and the statistics (*p<0.05) are
represented by Mann-Whitney comparisons. Data are representative of 4 independent
experiments.

CHAPTER FIVE
DISCUSSION
IL-22-producing cells are present in the human thymus
It was recently reported that IL-22-producing ILCs are present in the mouse
thymus, and play a critical role in the proliferation and regeneration of thymic epithelial
cells following thymic insults (6). IL-22-producing cells, particularly the ILC3s have
been shown to be present in most secondary lymphoid tissues in humans and mice (9-13,
53). In fact, IL-22 is constitutively produced by ILC3s in the small intestine. Studies have
demonstrated that the ILC3s in the gut produce IL-22 under steady states through ILR1MyD88 signaling (18). Furthermore, in the gut, IL-22 protects intestinal epithelial cells
from bacterial infections through the production of antimicrobial peptides and promotes
tissue repair through the induction of epithelial cell proliferation (11).
However, it is still unknown whether ILC3s are present in the human thymus.
Here we have investigated the presence of IL-22-producing cells in the human thymus.
Our analysis of ex vivo thymocytes from pediatric thymus demonstrated that there are
LIN- RORγt+ IL-22+ cells present in the human thymus at the protein and mRNA levels.
We did see a variability in the percentage of LIN- RORγt+ IL-22+ cells; these variations
may simply be due to the biological variability between the patients.
Alternatively, it is possible that the health condition of the patients at the time of
their surgery when their thymus was removed, as well as, the medications they were
administered before or during the surgery could contribute to the variability observed. At
this point these are only mere speculations; however, the present or absence of other
health conditions that may have affected thymic function should be examined in
38
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future studies. In addition to ILC3s in the thymus, we reported that at steady state there
are CD4+ cells, CD8+ cells, CD3+CD4-CD8- (possible γδ T) cells, and CD4+CD8+
(DP) cells which express IL-22 at the protein level.
Although we observed low to undetectable levels of IL-22 mRNA expression in
CD4+ cells, CD8+ cells, CD3+CD4-CD8- cells, and CD4+CD8+ cells within the
thymocyte population this is somewhat not surprising. Wolk et al., and others have
previously reported that the highest expression of IL-22 is observed following infection
or damage, when T cells such as CD8+ T cells, CD4+ T cells and γδ T cells are activated
(8). Therefore, it is likely that in the absent of tissue damage or inflammation in the
thymus, DP T cells, and γδ T cells IL-22 mRNA levels are lower than ILC3s, CD8+ T
cells, and CD4+ T cells and these cells may require activation following injury or
inflammation to produce a higher level of IL-22 mRNA expression. It is also possible
that some population of cells that produce IL-22 at the protein levels in the thymus at
steady state are so low that it is more difficult to detect their IL-22 mRNA expression.
Therefore, more sophisticated technology may be need to be employed to answer these
questions.
Furthermore, most studies evaluated IL-22 mRNA expression in murine
stimulated- T cells lines and stimulated -human peripheral blood, have reported that IL22 can only be found in activated T cells (13). On the other hand, other studies have
demonstrated that T cells can produce IL-22 under steady state conditions (12). These T
cells include human CD4+ T cells and CD8+ T cells that can differentiate into IL-22producing cells known as TH22 and TC22, respectively. The TH22 and TC22 cells are
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normally found present in the skin of normal and inflamed individuals (12). Furthermore,
naïve T cells can secrete IL-22 without the need for T effector cells polarizing cytokines
(10).
Studies have indicated that IL-22 involved in homeostasis at barrier organs in the
individuals healthy as well as in individuals with inflamed states (9-13). Therefore, it is
likely IL-22 release is governed by factors such as internal micro-environmental stimuli,
the cytokine milieu and the tissue in which IL-22 is expressed. Therefore, it is highly
possible that in the thymus, direct interaction between thymocytes and different type of
thymic stromal cells could induce the necessary stimuli for IL-22 expression. The fact is
that the mechanism underling IL-22-expressing cells differentiation, development and
regulation in the human thymus is yet to be studied.
Thymic epithelial cells do not modulate IL-22 expression ex vivo
It is well established that direct contact between developing thymocytes within
the thymus and thymic epithelial cells can induce the expression of different cytokines by
the thymic epithelial cells (12, 13 and 15). These cytokines in turn are known to induce
expression of other cytokines; certain the cytokine profile can induce differentiation of
ILC3s and T cell subsets (Figure 2). We next assess the effects of thymic epithelial cells
on LIN- RORγt+ cells in terms of IL-22 expression. We co-cultured thymocytes with
thymic epithelial cells and evaluated the percentage of IL-22- producing cells using flow
cytometry. Although we observed a trend suggesting an increase in ILC3 RORγt+
expressing IL-22 (Figure 7) following thymocyte/TEC co-culture, there were no
statistical significant differences between cell cultured with or without TEC. The finding
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indicates that TEC alone may not be sufficient to modulate IL-22 expression in ILC3s in
the human thymus.
IL-22 production by most cell subsets requires cytokine induction such as, IL-7,
IL-1β, IL-23 and IL-6 (33-46). Studies have shown that ILC3 development and
proliferation require a milieu of cytokines particularly in an infectious state or during
repair. These includes IL-23 and IL-1β which are required by ILC3s for effector function
both in vitro and in vivo (41, 45). IL-1β in combination with IL-17 and IL-2/IL-15 can
induce the proliferation, accumulation and activation of ILC3s (41). Other important
cytokines include IL-7, TSLP, and SCF these cytokines are necessary for ILC3
maintenance (33, 41, and 42). These cytokines are produce by cells such as fibroblast,
epithelial cells and different stromal cells and should be produce in our co-culture system.
However, the production of other cytokines such as IL-23 may require the present of
other cell types that is a normal part of the thymic stroma such as CD103+ DCs. Studies
have shown that DCs regulated ILC3s activities (17). ILCs can be activated directly by
dendritic cells (DCs) cytokines such as IL-23 (6, 17). Therefore, it is also likely that DCs
as well as thymic epithelial cells may be required for IL-22 production by LIN- RORγt+
IL-22+ cells.
Another alternative is that the cytokines that are produce in our co-culture system
could be blunting IL-22 expression. In fact, the TECs in our co-culture system express
TGF-β, and studies have shown that TGF-β can drive IL-17 production and inhibit IL-22
expression in Tc22 and Th22 cells depending on the context of the tissue (11, 15, and
33). Studies have shown that ILC3s can switch from producing of IL-22 to produce TNF
and IL-2 (33). Furthermore, it has been previously demonstrated that the loss of RORγt

42
stability due to the absence of IL-7 and its ability to enhance LTα1β1 expression can
result in the conversion from IL-22-producing ILC3s (LTi) into IFN-γ-producing ILC3s
(19,33, 34). Studies have shown that ILC3s generated in the presence of IL-2, IL-15 and
IL-12 cytokines can result in the conversion from IL-22-producing ILC3s (LTi) into IFNγ-producing ILC3s (33-35). Whether this is true for other ILC3s in the human thymus is
unknown. To analyze these possibilities in the future, it is necessary to measure the
supernatant in the co-culture assay using ELISA to determine whether cytokines such as
IL-7, IL-1β, IL-23, IFN-γ, IL-2, TNF and IL-6 are produced in our culture system.
Furthermore, flow cytometry analysis of thymocytes co-cultured with TEC with the
addition of cytokines combination (IL-7, IL-1β, IL-23 and IL-6) should be performed to
elucidate the mechanism of IL-22 regulation by TEC.
Circulating LIN- RORγt + cells can produce IL-22 independent of thymic epithelial
cells in vitro
IL-22- producing cells are present in peripheral blood mononuclear cells (17, 15,
and 43). We have also shown that the total PBMC have higher expression levels of IL-22
mRNA (Figure 5). Studies have indicated that the microenvironment of ILC3s play a role
in their development and function (47-53). This led us to look at the ability of thymic
epithelial cells to modulate expression of IL-22 in circulating ILC3s.We observed a trend
towards increase in IL-22 secretion (Figure 7) by RORγt-expressing ILC3s following
PBMC /TEC84 co-culture. However, statistical analysis of our data showed conflicting
results. There was no statistical significant difference (Figure 11A) between cell cultures
with or without TEC84 using isotype control gating, but there was statistical significant
difference (Figure 11B) between cell cultured with or without TEC84 using
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RORγt negative control gating. These discrepancies may be due to more variance
generated using isotype control gating. We may be able to see a statistically significant
increase by increasing the number of experiments.
However, if we go by the isotype control gating and assume that thymic epithelial
cells alone may not be sufficient to modulate peripheral ILC3-derived IL-22 in vitro then
as mentioned above these results may be due to the nature of the cytokine production
profile in the PBMC that can act as stimulators that leads to IL-22 production in culture.
In supporting this notion, there are studies showing that TH22 cells in the peripheral
blood can be stimulated by dendritic cells promoting their differentiation from naïve to
IL-22- producing cells (12). Furthermore, TH22 are polyclonal TCRαβ+CD4+ T cells that
are autoreactive to CD1a, a MHC Class1 like molecules (12). Whether TC22 have a
similar population of cells is yet to be shown. Over all, in our co-culture sytem of PBMC
there may be factors increasing IL-22 expression by the IL-22-producing cells which
could explain why there is no difference between PBMC culture alone, and PBMCTEC84 co-culture.
Alternately, there are other factors that regulate the development, proliferation,
and maintenance of ILC3s and IL-22-producing T cells and can influence IL-22
production. These includes AHR, RORγt, STAT3 and Notch signaling (45-59). Possot C
et al., have shown that ILCs progenitors can develop independently of the thymic
environment under the influence of Notch 2 signaling (48). Therefore, it is of importance
to examine the role of Notch in the ability of ILC3s and T cells to produce IL-22.
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The role of Notch signaling in TEC modulation of IL-22 expression by LIN-ILRORγt + cells
Notch signaling is involved in several cellular processes such cellular
proliferation, border formation and program cell death (50). In mammalians, there are
four Notch receptors (Notch 1-4) that bind to five different Notch ligands (Delta-like 1, 3,
4 and Jagged 1 and 2). The role of Notch in the crosstalk between developing
thymocytes and thymic epithelial cells are well documented (50, 57). Thymocytes
express Notch receptors while Notch ligands genes such as the Delta like1, 3, 4 and
Jagged 1, 2 have been shown to be expressed by thymic epithelial cells (57). Studies in
mice have also shown that Notch signaling can upregulate IL-22 production from CD4+
T cells through the regulation of AhR expression (49). Studies have also shown that
Notch is involved in the activation and differentiation of CD8 + T cells (54, 58).
However, whether Notch can also induce IL-22 production by CD8 + T cells is unclear.
Mounting evidence has implicated a role for Notch signaling in innate lymphoid cell
development and function through the induction of Notch -1 and Notch 2 expression by
AhR (47, 48, 51, and 52).
Therefore, we next investigated the possibility that thymic epithelial cells mediate
IL-22 expression in ILC3s through Notch signaling. When PBMCs co-cultured with
TECDL4, there was a significant increase in the frequency of IL-22-producing cells
(ILC3s, RORγt+ CD4+ and RORγt+ CD8) when compared to PBMC cultured without
TEC. Whether the increase was mediated by Notch signaling remains to be determined.
Overall our data suggest that Notch signaling in particularly through DL4 ligand, at least
partly mediates the increase in the frequencies of IL-22 positive cells within the ILC3s,
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RORγt+CD8 + and RORγt+CD4 + T cells. However, we cannot exclude the possibility
that Notch mediates IL-22 expression indirectly thought Notch mediated effector
functions. Therefore, it is possible that Notch signaling contributed to the differentiation
of effectors cells (Th1, Th17, and Th22) which causes the induction of cytokines such as
IL-1β, IL-6 and IL-23 which can up-regulate IL-22 expression (58).
It is also important not to dismiss the potential effect of alloreactivity in the
induction of IL-22 because TECs and PBMCs do not come from the same donor and are
HLA-missed match. The fact is that the significant increase in the frequency of IL-22
expression by RORγt+CD8+ T cells and RORγt+CD4 + T cells could be a result of
activated allogeneic T cells responding to allogeneic TECs as in our co-culture system.
The allogeneic activated T cells may in turn cause increase production of cytokines that
can up-regulate the expression of IL-22 in the RORγt –expressing CD8+ and CD4+ T
cells and ILC3s independent of Notch signaling. We can rule out a role for Th17 effector
cells in the production of IL-22, since we did not detect IL-17 expression among the
PBMC when co-cultured with TEC (data not shown). With these data one may want to
infer that TEC, Notch signaling and allogeneic T cell activation is involved in modulating
effector functions leading to the upregulation of IL-22 by ILC3s and other IL-22expressing T cells in our co-culture system.
Taking all of this into consideration, we expected to see a difference between cells
that were co-culture with TEC84 and TECDL4, since TECDL4 has a higher expression
of DL4 ligand. However, we observed no significant difference in the expression of IL22 by ILC3s and T cells within the PBMC-TEC84 and PBMC–TECDL4 co-culture based
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on negative control gating strategy with RORγt, but we did observe a significant
difference based on our isotype control. I am unsure of the reason behind this difference
other than there been more variable using my negative control gating (may also be due to
technical differences in my culture system from experiment to experiment). These
variables may be also solved through performing experiments and adding more samples.
Another consideration is that although TEC84 cells express a low level of DL4, it
is possible that they have other ligands such as Jagged1 that could come into play. In this
scenario, the differential effects on IL-22 production could be in part due to differential
binding and signaling induced by various Notch ligands. It is also possible that within
our co-culture system different triggers may contribute to the cytokine–production
profile that induce IL-22-producing cells. These signals could be induced through a
combination of the TEC, Notch signaling and allogenic reactivity.
For now, more experiments are necessary to further elucidate the role of Notch
signaling in the regulation of IL-22 expression. Therefore, to clarify whether Notch
signaling through DL4 plays a role in TEC modulation of IL-22 expression by ILC3s,
CD8+ T cells and CD4+ T cells it is necessary to blocking Notch receptors via soluble
DLL4 to prevent Notch signaling and then examine IL-22, RORγt and cytokines
expression after PBMC-TEC co-culture. Furthermore, since other ligands such as Jagged
1 and 2 that are expressed by thymic epithelial cells are likely involved in the Notch
signaling, it is important to establish that only DL4 contribute to the increase frequency
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of IL-22 expression by RORγt–expressing CD8+ T cells, therefore, co-culture assays
should be perform using γ-secretase inhibitor to block Notch signaling.
Another experiment to answer these questions is to isolate LIN- cells from PBMC
and carry out co-culture assays to determine whether similar observation is seen when
LIN- cells are cultured alone without other lymphoid cells. I have attempted this
experiment, however we failed to detect any IL-22 expression. One of the problems I
think was due to the absence of the necessary cytokines to facilitate ILC3 maintenance
and proliferation. I did add in IL-7, however as mentioned in my introduction there are
many additional cytokines necessary for ILC3 survival and proliferation. Therefore, it is
essential to repeat these studies using these necessary cytokines.

.
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Figure 15. Model for the regulation of IL-22 production of circulating ILC3s. Notch
signaling mediates thymic epithelial cells up-regulation of IL-22 through nonspecific
regulation of notch on T cell effector functions. Allogeneic activated T cells generate effector
cells that produce cytokines which in turn induce IL-22 production. Direct contact between
thymic epithelial cells and circulating cells induce increase production of cytokines that upregulate IL-22 production in a notch independent or dependent notch manner.
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Significance of this study
Due to the importance of the thymus in establish peripheral tolerance and
educating T cells understanding how the thymus recover from damage should as radiation
and infection is relevant. IL-22 role in regenerating thymic epithelial cells is of
importance for the development future treatments and therapies as well as reestablishing
the thymic microenvironment following damages from chemotherapies and chronic
infections such as HIV, or even the effects cause by aging within the thymus.

CHAPTER SIX
MATERIALS AND METHODS
Cells and cell lines
Human Thymocytes: Cryogenically preserved ex vivo human thymocytes that were
previously isolated from human pediatric thymus tissue were quickly thawed and
incubated with thaw media (RPMI 1640 supplemented with 30% FCS, 100 µg/ml DNase
I, and 10 µg/ml gentamicin) for 1hr at 37oC. The dead cells were separated by FicollHypaque centrifugation using lymphocyte media (Corning, Cell gro). Cells were
resuspend in RPMI-1640 media with L-glutamine supplemented 5% fetal bovine serum,
100U/mL penicillin-streptomycin and 5% human AB serum then counted using
hemocytometer and used for co-culture assays and flow cytometry.
Peripheral mononuclear blood cells: Cryogenically preserved human peripheral blood
mononuclear cells were previously obtained from healthy patients’ blood and separated
were quickly thawed and incubated with RPMI 1640 supplemented with 5% FCS, 100
µg/ml DNase I, and 10 µg/ml gentamicin for 1hr at 37oC. The dead cells were separated
by Ficoll-Hypaque centrifugation using lymphocyte media (Corning, Cell gro). Cells
were then resuspend in RPMI-1640 media with L-glutamine supplemented 5% fetal
bovine serum, 100U/mL penicillin-streptomycin and 5% human AB serum and counted
using hemocytometer and used for co-culture assays and flow cytometry
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Thymic epithelial cells: Previously, a primary TEC culture from pediatric thymus tissue
was generated and described (4). TEC cell lines TEC84 express low levels of the human
Notch ligands, DL1 (<1000 transcript copies/µg RNA) and DL4 (3000 transcript
copies/µg RNA). The TEC-DL4 cell line was also previously generated by infecting the
TEC-84 cell line with retrovirus containing Migr1-DL4-GFP to enhance the potential of
the TEC-84 cell line. The generated cell line was termed TEC-DL4 cell line which
homogenously express GFP and express high levels of the human Notch ligand, DL4. (4).
TEC-84 and TEC-Dl4 were used in cell co-culture assays.
Flow cytometry and data analysis
For phenotyping experiments, 1-2x10⁶ thymocytes were treated for 2 hours with
monensin (Biolegend). Then incubated with Rat anti-human antibodies: anti-CD3 FTTC
(eBioscience; UCRHT) or anti-CD3 PE (eBioscience; UCRHT), anti-CD4 AF750
(eBioscience; RPAT4), anti-IL-17eF450 (eBioscience; RPATH), anti-CD8 PE-Cy7
(eBioscience; RPAT8), anti-CD56 PE (eBioscience; HCD56), or anti-CD56 AF700
(bioscience; HCD56) for 30 minute on ice in the dark. To characterize RORγ+ IL-22+
cells, following the above surface staining, the cells were fixed and permeabilized at RT
for 20 minutes with IC fixation buffer 1X Permeabilization buffer (eBioscience). Then
incubated with Rat antihuman IL-22 PerCpeF710 and RORγ+ APC, and for the isotype
control the cells were incubated with IL-22 Rat IgG2a PerCpeF710 (EBR2α) and RORγ+
Rat IgG2a APC (EBR2α) for 30 min an ice in the dark. The samples were analyzed using
BD LSRFortessa with tree star Flow Jo Software version 7.5.6.
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Cell Co-culture
Co-culture of thymocyte with TEC-84 or TEC-DL4, and co-culture of PBMC
with TEC-84 or TEC-DL4: 3x104 TEC-84 or TEC-DL4 were cultured at 3x104/mL in a
flat bottom 24- well culture plate with TE media (3; Dulbeecco’s modified Eagle’s
medium: F12 medium with 5% fetal calf serum, 5.5µg/ mL bovine insulin, 0.4 µg/ml
Hydrocortisone, 9ng/mL, cholera toxin, 0.3% adenine hydrochloride, 1mM sodium
pyruvate, 10ng/mL epidermal growth factor, 2.5 µg/ mL, amphotericin B, and 55 ng/ mL
gentamicin sulfate) until 50% confluent. 1-2X106 thymocytes/well or PBMC/well were
co-cultured with 50% confluent TEC-84 or TEC-Dl4in RPMI-1640 media with Lglutamine supplemented 5% fetal bovine serum, 100U/mL penicillin-streptomycin and
5% human AB serum. Cells were cultured for 2, 4 and 8 days then treated with monensin
for 2hrs before harvest. The total number of live cells harvested was counted on a
hemocytometer using Trypan blue (Life technologies) to exclude the dead cells.
Harvested cells were analyzed using flow cytometry to compare IL-22 and RORγt
expression of cells culture with or without TEC-84 or TEC-DL4.
Cell Sorting
For cell sorting of LIN- cells and T cell subsets, 40 x106 thymocytes were surface
stained with anti-CD3 FTTC (eBioscience; UCRHT, anti-CD4 AF750 (eBioscience;
RPAT4), anti-CD8 PE-Cy7 (eBioscience; RPAT8), anti-CD56 PE (eBioscience;
HCD56). FACS sort was performed with a FACSAria cell sorter (BD Biosciences).
Purified LIN- cells and CD8+ T cells, CD4 + T cells, CD8+CD4+T cells,
CD3+CD8+CD4+ T cells were used for RNA isolation described below.
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RNA isolation and Reverse Transcriptase-PCR
RNA from sorted cell subsets and total RNA from PBMC was isolated using
Trizol reagent (Sigma-Aldrich) according to the manufacturer's protocol. Isolated RNA
was then treated with DNase using Ambion DNA-free kit and 0.5 to 1 μg of RNA was
used for cDNA synthesis using the Invitrogen's SuperScript II synthesis kit with OligodT primers, per the manufacture’s instruction. The resulting cDNA was used for PCR
with primers as follow IL-22: forward 5’- TCTCCTTCCCAGTCACCAGTT
and reverse 5’TCATGATGGAGTTTGGCTTCC, GAPDH; forward 5’GCACCGTCAAGGCTGAGAAC and reverse 5’ GCCTTCTCCATGGTGAA. PCR
thermal cycler profile was run as follows: 95C 4min, 950C 15min, 550C 20 min, 720C 40
min, 720C 40 min, 720C 4 min 100C 5min.The PCR products were run on a 1.8% gel,
then stained with ethidium bromide and image using BioRad ChemiDoc XRS + w/image
lab software.
Statistical Analysis
Statistical analysis was performed using Prism 5.0 (Graph Pad software).
Comparison between two groups was performed with the unpaired Man- Whitney U test,
values of p<0.05 are considered statistically significant.
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